profit from every $100 of sales.

INLIF
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
It has no yearly profit to compare the price with.
It holds more cash than debt.
Money in, money out
What INLIF sold, what it kept, and what it did with the cash.
Sales went from $6.65 million in 2022 to $18.4 million in 2025, with -$5.45 million of profit last year.
INLIF vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
INLIF | No profit yet | ||
Everpure | 188.6× · Very expensive | ||
Ingersoll Rand | 56.2× · Expensive | ||
Otis Worldwide | 21.3× · Fair price | ||
Dover | 25.8× · Fair price |
AI analysis
An AI analyst reads INLIF's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 7 | 13 | 16 | 18 | |
| 2 | 4 | 5 | 4 | |
| 1 | 1 | 1 | -6 | |
| 1 | 2 | 2 | -5 | |
| 1 | 1 | 2 | -5 | |
| 0.59 | 1.49 | 1.77 | -5.28 | |
| 34.5% | 33.0% | 28.8% | 23.3% | |
| 9.8% | 11.0% | 8.2% | -31.6% | |
| 8.1% | 10.7% | 10.2% | -29.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 11 | 16 | 18 | 25 |
| Cash | 0 | 1 | 2 | 7 |
| Total debt | 2 | 4 | 5 | 5 |
| Total liabilities | 3 | 7 | 8 | 9 |
| 8 | 9 | 10 | 16 | |
| 1 | 1 | 1 | 1 | |
| 4.8% | 9.5% | 9.6% | -20.1% | |
| 6.9% | 15.1% | 15.6% | -33.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 0 | 2 | -2 | |
| 0 | 0 | 0 | 0 | |
| 1 | 0 | 2 | -2 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | 0 | 0 | 5 |
Valuation
- –
- –
- –
- 0.3×
- 0.0×
- –
- –
- -273.0%
- -713.7%
- 0.0%
Profitability
- 23.3%
- -31.6%
- -29.6%
- -1.3%
- -4.5%
- 0.5%
- -4.7%
- -3.1%
- -5.8%
- 8.8%
Growth
- +40.4%
- –
- −234.1%
- –
- +2.3%
Financial health
- -0.4×
- 0.29
- 18.9%
- -4.7×
- 2.11
- 1.48
- 0.78
How it ranks in Industrials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about INLIF
Is INLIF a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the INLIF AI analysis
What does INLIF do?
INLIF Limited engages in researching, developing, manufacturing, and selling injection molding machine-dedicated manipulator arms under the iNLIF brand name in the People's Republic of China. It is in Industrial - Machinery.
Does INLIF pay a dividend?
No. INLIF does not pay a dividend at the moment.
Is INLIF stock halal?
No. INLIF does not pass our halal screen: its debt is 615% of its market value, at or above the 33% limit. How we check
How has INLIF stock done over the past year?
Down 87.6% over the past twelve months, to $0.70. It traded between $0.18 and $863.20 and is 99.9% below its high.
Who are INLIF's competitors?
The largest listed companies in the same industry are Everpure, Ingersoll Rand, Otis Worldwide and Dover. The peers table on this page compares their profit, growth and price with INLIF's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.



